- Home
- GROY vs HQL Comparison
GROY vs HQL Comparison
Compare GROY & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | GROY | HQL |
|---|---|---|
| Founded | 2020 | 1992 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Investment Managers |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 492.8M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | GROY | HQL |
|---|---|---|
| Price | $4.21 | $16.85 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $5.95 | N/A |
| AVG Volume (30 Days) | ★ 2.6M | 123.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.56% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.79 |
| Revenue | N/A | N/A |
| Revenue This Year | $62.71 | N/A |
| Revenue Next Year | $134.66 | N/A |
| P/E Ratio | ★ N/A | $21.16 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.23 | $10.55 |
| 52 Week High | $5.45 | $17.80 |
Technical Indicators
Market Signals| Indicator | GROY | HQL |
|---|---|---|
| Relative Strength Index (RSI) | 43.74 | 53.25 |
| Support Level | $4.00 | $16.40 |
| Resistance Level | $4.61 | $17.51 |
| Average True Range (ATR) | 0.21 | 0.29 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 18.25 | 81.10 |
Price Performance
Historical ComparisonAbout GROY Gold Royalty Corp.
Gold Royalty Corp is a precious metals-focused royalty and mineral streaming company. The company offers creative financing solutions to the metals and mining industry. The company's mission is to acquire royalties, streams and similar interests at varying stages of the mine life cycle to build a balanced portfolio offering near, medium and longer-term attractive returns for investors. It has its business as a single operating segment, being the investment in royalty and mineral stream interests. The company derives maximum revenue from Canada.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.